Piper Sandler Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)
TipRanksFeb 23 20:33
AbCellera Biologics Stock Upgraded to Buy on Q4 Results, R&D Progress
InvestingFeb 22 23:46
Benchmark Upgrades AbCellera Biologics to Buy From Hold, Price Target Is $9
MT NewswiresFeb 22 20:03
AbCellera Biologics Analyst Ratings
BenzingaFeb 22 20:03
AbCellera Biologics Analyst Ratings
BenzingaFeb 21 22:00
Stifel Nicolaus Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)
TipRanksFeb 21 21:14
Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Teladoc (TDOC) and Alnylam Pharma (ALNY)
TipRanksFeb 21 20:31
Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and AbCellera Biologics (ABCL)
TipRanksFeb 21 10:30
Buy Rating Affirmed for AbCellera Biologics Amid Positive TCE Program Prospects and Strategic Pipeline Focus
TipRanksJan 11 20:46
Keybanc Initiates Coverage On AbCellera Biologics With Overweight Rating, Announces Price Target of $6
BenzingaDec 5, 2023 19:03
AbCellera Biologics Analyst Ratings
BenzingaDec 5, 2023 19:01
Leerink Partners Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)
TipRanksDec 1, 2023 21:41
TD Cowen Remains a Buy on AbCellera Biologics (ABCL)
TipRanksNov 3, 2023 09:05
Piper Sandler Assumes AbCellera Biologics at Overweight, Announces Price Target of $20
BenzingaOct 13, 2023 18:29
AbCellera Biologics Analyst Ratings
BenzingaOct 13, 2023 18:26
Benchmark Maintains Buy on AbCellera Biologics, Lowers Price Target to $12
BenzingaAug 31, 2023 20:37
AbCellera Biologics Analyst Ratings
BenzingaAug 31, 2023 20:35
AbCellera Biologics Analyst Ratings
BenzingaAug 4, 2023 21:10
Berenberg Bank Adjusts AbCellera Biologics Price Target to $34 From $38, Maintains Buy Rating
MT NewswiresAug 4, 2023 19:30
Berenberg Bank Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)
TipRanksAug 4, 2023 11:25
No Data
No Data